M-A: Intravenous tranexamic acid in surgical patients is not associated with increased risk of thromboembolic events and mortality

Association of Intravenous Tranexamic Acid With Thromboembolic Events and Mortality: A Systematic Review, Meta-analysis, and Meta-regression – JAMA Surgery (free for a limited period)

Invited commentary: Tranexamic Acid and Safety in the Right Patient – JAMA Surgery (free for a limited period)

Commentary on Twitter

Systematic review and meta-analysis of 216 RCTs (N=125,550 patients) finds no excess risk of thromboembolic events among surgical patients who received intravenous tranexamic acid (TXA) compared with placebo or no treatment.https://t.co/C18EJjpR7p

— Lucas Morin (@lucasmorin_eolc) April 18, 2021